West Pharmaceutical Services | WST - Ordinary Share Capital


West Pharmaceutical Services reported $70.4M in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
Align Technology USD 71.62M 1000 Jun/2026
Baxter International USD 517M 549K Jun/2026
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Charles River Laboratories USD 47.73M 439K Jun/2026
Cooper Companies USD 195.11M 14K Mar/2026
Dentsply International USD 200.3M 700K Mar/2026
Haemonetics USD 46.83M 82K Dec/2025
ICU Medical USD 24.69M 2K Dec/2025
Insulet USD 69.26M 1.08M Mar/2026
Integra LifeSciences USD 77.78M 39K Jun/2026
IQVIA Holdings USD 164.6M 2.3M Jun/2026
J&J USD 2.41B 1.35M Mar/2026
Medtronic USD 1.28B 1.38M Dec/2025
Merit Medical Systems USD 59.71M 55K Jun/2026
Neogen USD 217.7M 27K Mar/2026
OraSure Technologies USD 70.39M 1.87M Dec/2025
Quidel USD 68.1M 200K Mar/2026
Repligen USD 56.43M 28K Jun/2026
Solventum Corp USD 173.53M 40.79K Mar/2026
STAAR Surgical USD 49.78M 377K Mar/2026
Terumo JPY 1.48B 11K Mar/2026
Utah Medical Products USD 3.18M 2K Mar/2026
West Pharmaceutical Services USD 70.4M 500K Jun/2026